REBIF

Google image searchProduct monograph

Active ingredient

interferon beta-1a, 44 MCG/0.5 ML

DIN: 02237320

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: PRE-FILLED SYRINGE

Schedule: Prescription

Company: EMD SERONO, A DIVISION OF EMD INC., CANADA

Date: 24-FEB-1998

ATC:

• L03 — IMMUNOSTIMULANTS (ATC, ATC/DDD, )
• L03A — IMMUNOSTIMULANTS (ATC, ATC/DDD)
• L03AB — Interferons (ATC, ATC/DDD)
• L03AB07 — INTERFERON BETA-1A (ATC/DDD)

Reference brand drug: Avonex, Rebif

Pharmaceutical standard: MFR

External Links for Rebif

Search on Google

• Rebif side effects
• Rebif dosage
• interferon beta-1a side effects
• interferon beta-1a dosage